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Background
Hyperplastic polyposis syndrome (HPS) is a colorectal
cancer (CRC) predisposition of unknown genetic
aetiology that is characterised by the presence of mul-
tiple serrated polyps throughout the colon, and an
increased risk of having a first-degree relative with
CRC [1-3]. Though there is a trend for association
between CRC and a higher number of polyps, patients
with at least one colonic conventional adenoma have
an increased risk of CRC compared to patients without
conventional adenoma (odds ratio: 3.6) [2]. HPS was
first thought to represent the familial model for the
serrated neoplasia pathway, as an analogy to the famil-
ial adenomatous polyposis syndrome for the adenoma-
carcinoma pathway. However, CRC in HPS patients
appears to arise from both conventional adenomas and
serrated polyp subtypes. To further define the carcino-
genesis of HPS related colorectal neoplasia, we sought
to characterise the histological features and the mole-
cular alterations of the different types of benign polyps
arising in HPS patients both in contiguity with and
remote from CRC.
Methods
A total of 151 patients diagnosed with at least 5 ser-
rated polyps outside the rectum were recruited from
high-risk genetics clinics. Polyp counts were extracted
from colonoscopy reports. Polyps, including contiguous
polyps, and CRCs underwent pathology review and
testing for KRAS codon 12 and 13 and BRAF V600E
somatic mutations.
Results
CRC was identified in 56 patients (37%) with 31/56
(55%) being females. The mean polyp count in patients
with CRC was 58, and their mean age was 52 years.
A total of 65 CRCs were available for analysis. Where
site was known, most CRCs 43/61 (71%) arose in the
proximal colon; however, only 19/58 (33%) of CRCs
demonstrated a BRAF V600E mutation. Somatic KRAS
mutations were less frequent at 9/48 (19%). Contiguous
polyp was seen in 16/53 (30%) evaluable CRCs, and of
these 4 (25%) were tubular adenomas, 5 (31%) were
tubulo-villous adenomas and 1 (6%) was a villous ade-
noma. Overall 10/16 (63%) showed conventional adeno-
matous morphology whereas 6/16 (37%) had serrated
morphology. BRAF mutation was present in 5/16 (31%).
CRC was present in more than one-third of clinic-based
individuals who presented with multiple serrated polyps.
Conclusion
Despite a high serrated polyp count, only one-third of
these CRCs demonstrated a BRAF V600E mutation, the
molecular hallmark of the serrated neoplasia pathway,
suggesting that though multiple serrated polyps act as a
marker of an abnormal mucosa, the majority of CRC in
these patients may arise through other mechanisms.
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